Autologous Stem Cell Transplant Should Remain Standard of Care for Certain DLBCL Patients, Expert Says
Dr. Nirav Niranjan Shah explains the data behind why autologous stem cell transplant should remain the standard of care for patients with relapsed chemo-sensitive DLBCL.